The Journal of antimicrobial chemotherapyPseudomonas aeruginosaAztreonamCeftazidimeAzabicyclo CompoundsMicrobial Sensitivity Tests
Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa.
Sophie E Müller, Sabryna Junker, Jacqueline Rehner, Maximilian Förster, Andreas Keller, Leidy-Alejandra G Molano, Sören L Becker
Published: 202510.1093/jac/dkaf376
Abstract
BACKGROUND AND OBJECTIVES: MDR Pseudomonas aeruginosa is difficult to treat, despite some new beta-lactam/beta-lactamase inhibitors. A combination of ceftazidime-avibactam and aztreonam (CAZ/AVI + AZT) is frequently used to treat Gram-negative bacter…
Preview only. Read the full abstract at the source